Date	Period	Revenue/Estimate	Earnings Call
May 12, 2023	2023/Q1	35.000M / --	--
Nov 4, 2022	2022/Q3	358.000M / --	--
May 13, 2022	2022/Q1	193.000M / --	--
Nov 5, 2021	2021/Q3	125.000M / --	--
May 7, 2021	2021/Q1	62.000M / --	--

DatePeriodRevenue/EstimateEarnings Call

May 12, 20232023/Q135.000M / ----

Nov 4, 20222022/Q3358.000M / ----

May 13, 20222022/Q1193.000M / ----

Nov 5, 20212021/Q3125.000M / ----

May 7, 20212021/Q162.000M / ----

Unlock Free Earnings Estimates

Open Account

Oncolys BioPharma Earnings Reports

Oncolys BioPharma: Summary of financial results for the 3rd quarter of the fiscal year ending 2024/12 [Japanese GAAP] (unconsolidated)

Nov 7 23:00 ET

Oncolys BioPharma: Confirmation letter

Aug 9 02:07 ET

Oncolys BioPharma: Half Year Report - Term 21 (2024/01/01 - 2024/12/31)

Aug 9 02:07 ET

Oncolys BioPharma: Financial results for the second quarter (interim period) of the December 2024 fiscal year based on Japanese standards (non-consolidated).

Aug 9 02:00 ET

Symbol Price % Chg

Beauty Kadan Holdings

KODAMA CHEMICAL INDUSTRY

4222

440 +22.22%

See the daily top gainer.